The median age for cancer diagnosis across the BRCA1/2 mutation carriers was 46 years, in the CHEK2 group it was 42.5 years, 44.8 years for ATM, 48.6 years for PALB2, 44 years for MUTYH, and 45.6 years for BLM. Here, BRCA1 is linked to cancer.